Hepatocellular carcinoma (HCC) is the fifth most common cancer in Korea. Diverse paraneoplastic syndromes can occur in patients with HCC, but parathyroid hormone-related peptide (PTH-rP)-induced hypercalcemia is uncommon. Hypercalcemia due to PTH or particularly PTH-rP-secreting HCC is associated with poor outcomes. We report a 71-year-old man who presented with symptoms of vague abdominal discomfort, somnolence, lethargy, nausea, vomiting, and weight loss. Imaging studies revealed a large HCC without metastasis. The laboratory findings showed elevated serum calcium level, low intact parathyroid hormone (iPTH) level and elevated PTH-rP level. These results led to a diagnosis of a PTH-rP-secreting HCC and paraneoplastic hypercalcemia. After emergency management of the hypercalcemia, the patient underwent an extended right hemihepatectomy with cholecystectomy. One year after the surgery, he is alive with normal calcium, PTH-rP, and iPTH levels. This case demonstrates that the rare phenomenon of life-threatening hypercalcemia caused by HCC should not be overlooked. These symptoms offer a good opportunity to diagnose HCC early. Radical tumor resection makes it possible to cure patients with PTH-rP-secreting HCC. (Korean J Gastroenterol 2015;66:122-126) 
INTRODUCTION
Hypercalcemia is a feature of paraneoplastic syndromes often associated with malignancies of the lungs, breasts, ovaries, lymphatic system, or other organs. Although there are various causes of hypercalcemia in malignancies, parathyroid hormone-related peptide (PTH-rP)-associated hypercalcemia is the most common cause. 1, 2 According to the National Cancer Information Center (www.cancer.go.kr) in Korea, hepatocellular carcinoma (HCC) was the sixth most common cancer diagnosed in 2012, after thyroid cancer, stomach cancer, colon cancer, lung cancer and breast cancer. Patients with HCC may display a variety of paraneoplastic syndromes including hypercholesterolemia, hypoglycemia, erythrocytosis, and hypercalcemia. 3, 4 A few cases of hypercalcemia associated with PTH-rP-secreting HCC have been reported. However, no case that was cured has been described in Korea. Herein, we describe a 71-year-old man who was cured of a PTH-rP-secreting HCC by undergoing complete tumor resection. 
CASE REPORT
A 71-year-old man presented with a four-month history of vague abdominal discomfort, somnolence, lethargy, nausea, vomiting, weight loss of approximately 7 to 8 kg, and poor oral intake. Because of these symptoms, abdominal ultrasonography was performed at a local clinic, revealing a large lesion in the liver. The patient was referred to our hospital. His height and weight were 167.3 cm and 56 kg. His medical and family history did not appear to contribute to the present illness. He had not undergone any regular screening for HCC. 
김은경 등. 부갑상선 호르몬 관련 펩티드 분비 간세포암종
The Korean Journal of Gastroenterology Immunohistochemical staining of the tissue showed positive staining for glypican-3, negative staining for CA 19-9, and negative staining for PTH (Fig. 2) . All of the histopathological findings were compatible with our pre-operative diagnosis.
Two weeks after the surgery, the patient was found to have a calcium level of 8. 
DISCUSSION
The risk of hypercalcemia induced by PTH-rP associated with HCC was first assessed in 1982 in a retrospective study.
Of the 152 patients analyzed, 5.2% had hypercalcemia due to HCC without bone involvement. 5 A study in the Korean
Journal of Hepatology reported that the prevalence of paraneoplastic syndromes associated with HCC in Korea is 35%
in Korea is 43.6%. 2 The most common paraneoplastic syndrome was hypercholesterolemia (14.5%), followed by hypoglycemia (12.7%), and hypercalcemia (7.8%). In summary, we presented a case of HCC that secreted PTH-rP, which induced symptomatic hypercalcemia. This case emphasizes that symptoms of paraneoplastic syndrome such as hypercalcemia may be helpful to diagnose HCC at the resectable stage and to receive surgical cure.
